|
 
- 积分
- 3495
- 威望
- 3495
- 包包
- 4879
|
美国冷泉港和国际干细胞协会（ISSCR）联合举办的细胞编程和重编程会议（Joint CSH Asia/ISSCR Conference on Cellular Programs & Reprogramming），于2011-10-24晚到2011-10-28中午结束，共开了3天半。来自世界各地的46个演讲者，围绕以下范围：1.Human Stem Cells; 2.Control of Pluripotency; 3.Differentiation Mechanisms; 4..Cell Interactions; 5.Molecular Control; 6.Cell Lineage; 7.Cell Therapies. 进行演讲。只采取全体大会演讲的形式，没有分会场交流。全体参会人数约430人，国内参会者应在一半以上。1 C& }6 l9 n% {
) D2 m# x( O5 E( [/ v$ Y
几点参会评论：5 A# _( c& M0 |$ x+ t+ r* W5 A) ]0 E
1.本次会议演讲范围较广，主要是干细胞的基础演讲，大概2个演讲者提到干细胞临床治疗，因此对临床医师受益有限。
* V; f; v9 A& M8 Q2.许多国际著名干细胞领域权威给予精彩演讲，且绝大部分演讲内容未发表，但视乎没有让人感觉“耳目一新、眼前一亮”的报告。
7 f% ?9 `1 S7 v% {3.国内干细胞大牛仅裴端卿、邓宏魁参会（小牛惠立建也给talk），这样的干细胞国际盛会，又是在中国举办，国内其他干细胞大牛到了哪里？为什么不参会？我非常想见到国内权威能向国际权威提几个精彩的问题，并进行辩论，但可惜没看到，只是邓宏魁、惠立建各提了一个基本的问题。国内研究生参会较多，且提问较积极，虽然问题较基本、英文发音不准，但不怯场，值得表扬。
* I/ {8 A7 `2 }4 a4.国际大佬基本上天天参会，较容易见到，也愿意回答问题，如国际皮肤干细胞的权威Elaine Fuchs教授，经常提问题，也天天被学生包围，不像国内某些大佬，一演讲完就找不到人了，像是怕见人。
; F/ |9 N2 @! v& X7 w: `* u5.大家几乎一致认为会议组织的很好，住宿条件非常好，5星级宾馆，宾馆周围环境非常优美。会议伙食也非常好，已听到多人抱怨说吃胖了，回去要减肥。本人多次在国外参加ISSCR组织的年会，不得不说这是吃得最好的一次。会议结束前晚组织的具有苏州特色的文艺表演，让一些国外参会者看的眼都直了。( m0 i& i2 ?9 M! f! d
* u, A1 p4 r8 ?/ ?大会演讲嘉宾有：. J( Z# D5 c. R0 ^( d1 K
1.Monday, October 24( t7 k, s1 c/ }. T& I) F% t. q
Welcome and Overview
' O9 x* p0 b5 i a4 |; T! I w- PChairperson: Ronald D. McKay, PhD
! ^4 N, J9 G9 m& \! |9 _$ b6 m4 |6 K( n
Opening Keynote: Elaine Fuchs, PhD, The Rockefeller University, USA " v, F4 x. Q" O |. ^( R/ y/ s5 |
# S( r P \ a* b1 z# a7 t8 Q% T' A2.Tuesday, October 25 Session I: Human Stem Cells, m+ Y+ H2 w4 s$ ?# [& f
Chairperson: Hongkui Deng, PhD
+ t/ i2 ?# ^$ Q. w3 O5 Z) I& Q+ R% ~& z* O0 h& k! n3 ]
Fred Gage, PhD, Salk Institute for Biological Studies, USA
# A; F1 j I$ R' `' wEsther Y. Son, Howard University
3 f& z0 Z5 }* r) AGong Chen, Pensylvania state University,! S1 L7 n6 i; ?: U6 o$ w
Wolf Reik, MD, PhD, The Babraham Institute, United Kingdom 6 {0 G1 S0 D+ o9 c- C8 x) o
Linzhao Cheng, PhD, Johns Hopkins University, USA
5 Z* a+ n" e& u% `Meng Li, Imperial College London* [3 C( I3 G1 C9 h
Joan Li, University of Gueensland
% @- L- T, G! |/ S5 `9 {% [; |9 JRichard A. Young, PhD, Whitehead Institute/M.I.T., USA' m/ S5 S' L' L0 W% x% A8 N& }: |
, ?5 V$ N# ]3 O3 N* X3.Session II: Control of Pluripotency
7 ]4 L8 w" c/ D, ?; fChairperson: Hongkui Deng, PhD1 c, g# R5 [7 R2 N+ P
, e1 L' ?) F- JMarius Wernig, MD, Stem Cell Institute, Stanford University, USA4 k: h( p- D$ Z2 r
Wenyu Zhou, University of Washington8 x$ [* _! H2 k0 l% h
Shuibing Chen, Weill Cornell Medical College7 S6 i" ^4 I7 u7 F7 M/ J
Jennifer Nichols, PhD, Cambridge Stem Cell Initiative, University of Cambridge, UK
4 ~" J4 i7 J7 |& N1 KYi Zhang, PhD, University of North Carolina, USA' j/ T. j2 R4 E6 P
Alice E. Chen, Stemgene Inc., Cambage
% t8 [7 |1 O. k4 SHitoshi Niwa, MD, PhD, Riken Center for Developmental Biology, Japan ( H0 D9 v/ e8 G9 ~* }
% j" a* S$ a& t. X( A4.Session III: Poster presentations with refreshments
@" R5 j$ ^0 \6 k. i
0 G/ I/ u6 `' d f6 }1 ~5 T, \2 n5. Wednesday, October 26 Session IV: Differentiation Mechanisms
5 i; i Q. q9 [& t q" cChairperson: V. Narry Kim, DPhill
2 m) X+ k# h( |/ z- n- r' }
, z: ^+ T- e. e' _, pDuanqing Pei, PhD, Guangzhou Institute of Biomedicine and Health, China
( N/ h& q0 M+ I0 n- VFeng Ma, CAMC,
7 ~9 Y! H6 w; V/ z8 _- H$ m# ?' }Eric Deneault, University of Montreal," A) e& I; p9 X$ k7 u
Hongkui Deng, PhD, Peking University, China
. d% v( F) {9 S% y( yDeepak Srivastava, MD, Gladstone Institute of Cardiovascular Disease, USA
y6 I. P d" Y" E; Z: m4 PLijian HUI, Shanghai,2 d Z/ X* ^8 q7 ^1 a1 @& E
Fiona Watt, DPhil, Cancer Research UK Cambridge Research Institute, United Kingdom5 ]# Y( o( k8 f, g$ H
! Z# I+ Q) d: P Y7 ]/ e- t6.Session V: Cell Interactions 9 m+ r6 e# c' l b) n+ i
Chairperson: V. Narry Kim, DPhill9 q. Q/ C) T" {* o$ ^' A, J. j2 F2 O
$ U/ W% A% h. A8 Y' ?
Linheng Li, PhD, Stowers Institute for Medical Research, USA & [" C7 m& c b( K' n8 U X
Feng Liu, Zoology of China
, g! N3 ^4 J6 V) y9 `( N2 o: nHiromitsu Nakauchi, MD, PhD, Institute of Medical Science, University of Tokyo, Japan# u9 M, I h3 ]+ }- Z) _# z
Toshio Suda, MD, Keio University School of Medicine, Japan1 s* |8 U) A. }, n% g/ s6 w6 b C* X
Guoping Fan, UCLA
; ^0 P; R9 e! ?+ i' k9 ZHideyuki Okano, MD, PhD, Keio University School of Medicine, Japan
& _2 _) O1 v/ R& H+ Q9 {* ]% m- z$ b$ e0 x0 g8 j
7. Thursday, October 27
8 V3 L3 R$ d2 d6 F) zSession VI: Molecular Control
) p6 j3 c1 W, k s/ TChairperson: Richard A. Young, PhD
) E" S8 ~+ M5 p H8 y
$ b! R- a( \. {# H9 _( pJoanna Wysocka, PhD, Stanford University, USA
# y6 V9 x; [$ r: YLin He, UC Berkeley! T0 I4 `# B8 }0 V; y" g7 [7 p* z5 Q- N
Andrew Xiao, Yale University
7 N; G# h. P: j! L. T W$ n1 n* ?. kV. Narry Kim, DPhil, Seoul National University, Korea0 h% b, d2 y; r( j E
Yukiko Gotoh, PhD, University of Tokyo, Japan$ B" l* @$ \3 i0 G0 U5 Y
Gang Wang, CAS, China+ x& M" l# ~# v. m
Shengxi Guan, New England Biolab, z# P! c7 G+ B: y3 o; v
Zhaoyu Lin, Nanjing University
) N$ a- w+ f( ?( o& HHaifan Lin, PhD, Yale University School of Medicine, USA
6 o0 U: g( B3 z8 l2 x$ v4 j4 N) ^! h+ O6 }! k! i! [4 I5 B2 G
8.Session VII: Cell Lineage+ {: L1 |7 m2 c8 H, J/ ]" Y
Chairperson: Richard A. Young, PhD; Q& e6 Y- Q; X
- U5 H. f1 D# w3 a" t4 FAnna-Katerina Hadjantonakis, MD, Memorial Sloan-Kettering Cancer Center, USA
0 _- ^/ _6 L( [4 m( j7 FLing-Ling Chen, PhD, Shanghai Institute for Biological Sciences, China1 k0 [0 j. Z; ^7 [; L6 z
Mark Krasnow, MD, PhD, Stanford University School of Medicine, USA6 \" X, B. H% Y# }( T9 c1 I
Ricardo A. Rossello, Howard Medical School8 x; Z, {, ~2 I. _( r: e, N
Sheng Ding, Gladstone Institute, UCSF. a5 T! Q; ?5 x$ B# n0 g" F& D5 z
) k) H3 }; t) m, f; T- o+ K9.Friday, October 28 Closing Session: Cell Therapies( t% x- e" ]1 X- E6 e
Chairperson and closing remarks: Ronald D. McKay, PhD( u8 i" h$ V5 M" E
/ U3 d; C9 Z0 K+ t1 z2 y
Lorenz Studer, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
1 x7 y* f8 R$ b9 {. DKevin A. D'Amour, PhD, ViaCyte, Inc., USA, r8 F2 C y0 a* i
Tariq Enver, The Weatherall Institute of Molecular Medicine, UK 3 ]: ?0 U0 S0 I
6 R, O' ?; x. u0 q9 b3 ~* }) i9 }3 ~& d
Closing Keynote: Gordon M. Keller, PhD, McEwen Center for Regenerative Medicine Ontario Cancer Institute, Canada
" p8 a& J# I# h9 n p+ D" ]6 U7 K- a# S+ N) b7 W
会场照片3 Y, Q' j6 ~* \% c7 ^7 |+ x- i& B
; N8 z, D1 \ L2 d" q: l- ~# Q) t7 d; U V* ?; }, b0 f5 Q
|
-
总评分: 威望 + 110
包包 + 220
查看全部评分
|
发表于 2011-10-31 20:02
发表于 2011-11-1 01:03
